H. Lundbeck A/S
- Country
- 🇩🇰Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 160
- Registration Number
- NCT05064371
- Locations
- 🇯🇵
DOI Clinic Internal Medicine, Hiroshima-Shi Naka-Ku, Hirosima, Japan
🇯🇵Mito Kyodo General Hospital, Mito, Ibaraki, Japan
🇯🇵Saitama Neuropsychiatric Institute, Saitama-Shi, Saitama, Japan
A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)
- First Posted Date
- 2021-10-01
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 131
- Registration Number
- NCT05064397
- Locations
- 🇺🇸
Cleveland Clinic - Neurological Institute, Cleveland, Ohio, United States
🇫🇷Hôpital Cimiez, Nice Cedex 1, Côte-d'Or, France
🇫🇷Hôpital Lariboisière, Paris, Île-de-France, France
Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 20
- Registration Number
- NCT05045781
- Locations
- 🇨🇳
zs-hospital Shanghai, Shanghai, China
A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 16
- Registration Number
- NCT05028673
- Locations
- 🇬🇧
LabCorp Clinical Research Unit Ltd, Leeds, United Kingdom
Vortioxetine to Prevent Return of Symptoms in Children With Depression
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2023-01-05
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 35
- Registration Number
- NCT05014919
- Locations
- 🇱🇻
Linda Keruze's Psychiatric Center, LLC, Liepaja, Latvia
🇺🇸AIM Trials, LLC, Plano, Texas, United States
🇷🇺Medicorehabilitation Research Center Phoenix, Rostov-On-Don, Rostov State, Russian Federation
Safety and Tolerability of Lu AG06474 in Healthy Young Men
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 79
- Registration Number
- NCT05003687
- Locations
- 🇺🇸
Quotient Sciences Miami, Miami, Florida, United States
A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Interventions
- Drug: Lu AG06466Drug: Placebo
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2023-02-03
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 37
- Registration Number
- NCT04990219
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇩🇪Universitätsklinikum Düsseldorf, Dusseldorf NRW, Germany
🇩🇪Center of Neurology, Hertie Institute for Clinical Brain Research, Tubingen, Germany
A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 25
- Registration Number
- NCT04976309
- Locations
- 🇩🇰
Danish Headache Center Rigshospitalet Glostrup, Glostrup, Denmark
A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia
- Conditions
- Fibromyalgia
- Interventions
- Drug: PlaceboDrug: Lu AG06466
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 3
- Registration Number
- NCT04974359
- Locations
- 🇺🇸
Collaborative NeuroScience Network LLC, Long Beach, California, United States
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 285
- Registration Number
- NCT04965675
- Locations
- 🇦🇷
Expertia S.A- Mautalén Salud e Investigación, Ciudad Autónoma de Buenos Aires, Ciudad Autónoma De BuenosAires, Argentina
🇦🇷Centro de Investigaciones Médicas Tucumán - PPDS, San Miguel de Tucuman, Tucumán, Argentina
🇨🇦London Health Sciences Centre -800 Commissioners Rd E, London, Ontario, Canada